Posts Tagged ‘OHSU Knight Cancer Institute’

Diversity focus: Research interns get hands-on lab experiences

The Center for Diversity and Inclusion thanks research faculty and postdoc fellows who are serving as mentors to the research interns who are part of the Ted R. Lilley Cancer CURE and Summer Equity internship programs. This summer, CDI has placed 26 high school and college students in research lab experiences throughout OHSU. The highly competitive programs drew over 200 applicants from across Oregon and the United States. Interns receive a stipend during their time … Read More

Jeffrey Tyner, Ph.D., receives prestigious early-career award from AAAS

Jeffrey Tyner, Ph.D., an assistant professor of cell and developmental biology in the OHSU School of Medicine and a member of the Knight Cancer Institute, is one of two recipients of the 2nd Annual Martin and Rose Wachtel Cancer Research Award from the American Association for the Advancement of Science (AAAS). Dr. Tyner received the award for research that simultaneously identifies cancer-causing mutations and drugs that target these mutations. Dr. Tyner’s award essay was published … Read More

Internal funding opportunites for cancer research

The OHSU Knight Cancer Institute is now accepting applications for two unique funding opportunities: The purpose of the Umpqua Bank Innovation Award for Pediatric Cancer Research is to cultivate outstanding pediatric cancer research by assisting in the generation of preliminary data for peer-reviewed national funding or career development proposals. Scientific excellence will be the key review element for applications with a priority on research that has the greatest potential to yield improvements in cancer therapy, … Read More

OHSU researchers receive Damon Runyon-Rachleff Innovation Award to unleash the power of imaging for cancer treatment

When doctors treat breast cancer patients with the latest targeted cancer drugs, many patients initially see an improvement but later relapse and develop a resistance to treatment. Researchers at Oregon Health & Science University believe that by developing better imaging technologies they will be able to see how molecules change and rearrange themselves in response to cancer treatment, ultimately allowing them to create more effective treatments with a lasting response. Summer L. Gibbs, Ph.D., and … Read More

December Basic & Translation Sciences Seminar Series schedule

The Basic & Translational Sciences Seminar Series, co-sponsored by the Knight Cancer Institute and the Department of Cell & Developmental Biology, provides an emphasis on fundamental science and translational research topics presented by leading extramural scientists. Upcoming speakers in December: December 2 at 4 p.m. in Vollum room M1441 – Markus Grompe, M.D., Director, Pape Family Pediatric Institute; Director, Oregon Stem Cell Center; Professor, Department of Pediatrics: “How to build human tissues in animals: the … Read More

Knight Cancer Institute Cancer Research Development Awards, due Dec. 6

The Knight Cancer Institute is calling for proposals for this year’s Cancer Research Development Awards. The purpose of this funding mechanism is to cultivate outstanding cancer research by assisting in the generation of preliminary data for peer-reviewed national funding and career development proposals. This mechanism is intended to support clinical, basic, or population-based research that is cancer focused. Scientific excellence will be the key review element for all applications. Interdisciplinary research, in which investigators from … Read More

Fluidigm to present state-of-the-art single-cell genomics technology, Nov. 8

The Fluidigm Corporation will be presenting on their single-cell genomics technology; an overview of the field of single-cell genomics and examples of applications on Friday, November 8 from 10 to 11 a.m. in Mac Hall 3189. This technology is currently deployed in the lab of Dr. Lincoln Shenje of the Knight Cardiovascular Institute. This research capability is made possible by the generous donation from the Knight Family, and this is one of the numerous ways in … Read More

November Basic & Translation Sciences Seminar Series schedule

The Basic & Translational Sciences Seminar Series, co-sponsored by the Knight Cancer Institute and the Department of Cell & Developmental Biology, provides an emphasis on fundamental science and translational research topics presented by leading extramural scientists. Upcoming speakers in November: November 11 at 4 p.m. in Vollum room M1441 – Lincoln T. Shenje M.D., Ph.D., Associate Professor, OHSU November 18 at 4 p.m. in Vollum room M1441 – Alana Welm, Ph.D., Assistant Professor, University of Utah, … Read More

Knight Cancer Institute showcased by Intel president at tech conference

As reported in Knight News, Intel President Renee James recently highlighted Intel’s collaboration with OHSU to advance personalized cancer medicine during her keynote address at the 2013 Intel Developer Forum in San Francisco on September 10. At about 15 minutes into her speech, James plays a video that shows a number of familiar faces and includes interviews with Brian Druker, M.D., and Joe Gray, Ph.D. After the keynote, Paul Spellman, Ph.D., was also interviewed for … Read More

Nobel Laureate David Baltimore to speak at OHSU this Friday, Sept. 20

The Research in Progress Seminar Series (RIPSS) invites you to attend this special talk featuring Nobel Laureate David Baltimore, Ph.D., Millikan Professor of Biology, California Institute of Technology. Dr. Baltimore will discuss strategies in “Preventing the Spread of HIV by Programing Muscle Cells to Make Broadly Neutralizing Antibodies.” The seminar will take place at 9 a.m. on Friday, September 20 in the OHSU Old Library Auditorium. About Dr. Baltimore David Baltimore is an American biologist, … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives